BRAFm+ Metastatic melanoma
What makes it different, makes it vulnerable

Why test for BRAF mutations?

Within these pages you’ll find information pertaining to prognostic factors in melanoma and evidence for characterizing BRAFm+ melanoma as a distinct disease with a potentially worse prognosis than wild-type BRAF melanoma, including differentiating disease and patient characteristics.